In device-detected AF, DOACs vs. aspirin or placebo reduce ischemic stroke and increase major bleeding.
meta_analysis · Level I
Where this comes from
- Record sourced from PubMed, PMID 38950401.
- Also identified by DOI 10.7326/ANNALS-24-00652-JC.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
McIntyre WF, Benz AP, Becher N, et al. <b>Direct oral anticoagulants for stroke prevention in patients with device-detected atrial fibrillation: a study-level meta-analysis of the NOAH-AFNET 6 and ARTESiA trials.</b> Circulation. 2024;149:981-988. 37952187.
Medical subject headings
- Aspirin
- Atrial Fibrillation
- Hemorrhage
- Ischemic Stroke